Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden

Thomas R. Collins  |  February 12, 2020

The National Institutes of Health’s $945 million HEAL initiative—Helping to End Addiction Long-Term—will include money for research on pain signatures associated with the transition from acute to chronic pain, how to manage pain more effectively and optimizing non-addictive therapies to treat pain. With pain as an important outcome, “arthritis is positioned to take advantage,” he said.

“Arthritis and rheumatic conditions are major sources of chronic pain, so more general attention to pain, as has been happening over the past seven years—and pain as a major risk factor for prescribed opioids, which is a large part of the current opioid crisis—mean that arthritis and rheumatic conditions should be getting more attention from both the pain and opioid communities as part of their own agendas.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Thomas R. Collins is a freelance writer living in South Florida.

References

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Barbour KE, Helmick CG, Boring M, et al. Vital  signs: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation–United States, 2013–2015. MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):246–253.
  2. Murphy LB, Cisternas MG, Pasta DJ, et al. Medical  expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res (Hoboken). 2018 Jun;70(6):869–876.
  3. Guglielmo D, Murphy LB, Boring MA, et al. State-specific  severe joint pain and physical inactivity among adults with arthritis—United States, 2017. MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):381–387.
  4. Theis KA, Steinweg A, Helmick CG, et al. Which  one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. Disabil Health J. 2019 Jul;12(3):411–421.
  5. Furner SE, Hootman JM, Helmick CG, et al. Health-related  quality of life of US adults with arthritis: Analysis of data from the behavioral risk factor surveillance system, 2003, 2005, and 2007. Arthritis Care Res (Hoboken). 2011 Jun;63(6):788–799.

Page: 1 2 3 | Single Page
Share: 

Filed under:Professional Topics Tagged with:ArthritisburdenCDCpublic health

Related Articles

    A Public Health Approach to Arthritis

    March 12, 2020

    ATLANTA—Rheumatic diseases have been the subject of a range of public health campaigns and reports over the past decade, but improving their visibility remains a work in progress, a Centers for Disease Control and Prevention (CDC) expert said at the 2019 ACR/ARP Annual Meeting. A growing attention to pain and the opioid crisis may help…

    Late Summer 2022’s Awards, Appointments & Announcements in Rheumatology

    August 14, 2022

    Charles G. Helmick III, MD, Retires After 42 Years with the CDC On Dec. 31, 2021, after 42 years of service, Charles (Chad) G. Helmick III, MD (Capt., USPHS, Ret.), officially retired from the Centers for Disease Control and Prevention. He joined the CDC in 1979, when Jimmy Carter was president, and served through eight…

    The 2018 ARHP Merit Awards & ACR Distinguished Fellows

    December 18, 2018

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

    The 2022 ARP President’s & Merit Awards

    November 6, 2022

    During ACR Convergence 2022 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences